Serotonin 1A receptors in the living brain of Alzheimer's disease patients
about
5-HT(1A) receptor function in major depressive disorderDrug Development in Alzheimer's Disease: The Contribution of PET and SPECTTurning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease PathogenesisMonoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesComparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humansMolecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Current and future uses of neuroimaging for cognitively impaired patients.Tracking Alzheimer's disease.Differential FDDNP PET patterns in nondemented middle-aged and older adultsEffective microPET imaging of brain 5-HT(1A) receptors in rats with [(18) F]MeFWAY by suppression of radioligand defluorination.Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET.Unveiling molecular events in the brain by noninvasive imaging.Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?Correlation of brain amyloid with "aerobic glycolysis": A question of assumptions?Monte Carlo simulations of absorbed dose in a mouse phantom from 18-fluorine compounds.Functional expression of SGLTs in rat brainAn immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.PET tracers for serotonin receptors and their applicationsPositron emission tomography scans obtained for the evaluation of cognitive dysfunction.Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy.Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementiaMolecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathwayProtein binding in patients with late-life depression.The serotonergic system and cognitive functionDepression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.Vascular risk and FDDNP-PET influence cognitive performance.Psychological well-being and regional brain amyloid and tau in mild cognitive impairment.Does Alzheimer's disease begin in the brainstem?Epigenetic dysregulation of brainstem nuclei in the pathogenesis of Alzheimer's disease: looking in the correct place at the right time?Current therapeutic targets for the treatment of Alzheimer's disease.PET/CT in diagnosis of dementiaAlzheimer's disease drug development: translational neuroscience strategies.Current status of positron emission tomography radiotracers for serotonin receptors in humans.Overview of experimental models of the blood-brain barrier in CNS drug discovery.Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.The role of positron emission tomography imaging in understanding Alzheimer's disease.Neural correlates of apathy in late-life depression: a pilot [18 F]FDDNP positron emission tomography study.Monoaminergic neuropathology in Alzheimer's disease.
P2860
Q24643511-5A93EC75-B872-42BD-AC7B-A9A71496AAD0Q26749755-0982DB1A-4F97-406B-996F-EA2D866D6CE0Q27027221-6AF2DC69-4FE7-46FE-A979-AC0C4B50A4EAQ28066691-1D1FA286-3617-4BAE-ADA9-91297F933AF3Q30724808-37F96E8D-02A2-4196-AB1E-3AFDB9C52F98Q31047131-5325A691-45D5-42FE-8F14-7CB32C0361A4Q31143267-80A96C5F-4EA2-4118-9FB0-22E9D4E51F68Q33281339-7B1EAD37-D2CD-494E-B90A-A871D4042148Q33899796-92BC2AE3-5AD5-4D7D-A26F-778F981DD460Q34033357-D7C3F5C8-7135-4BAB-9133-87FE6354E71DQ34036060-CDF56DC7-4519-401B-821F-5C9808DDD8DBQ34046040-65D2B6C1-FA1A-4856-9B70-9773BFE7AAACQ34078777-54CDE37B-6A0B-47E5-922A-CEC501C7F763Q34200085-88E6EB61-81CA-4C87-87D1-3754F88E4206Q34425601-0C493EE2-C853-4A5C-85F0-57721EC0C351Q34426413-32597B4F-86E4-4E93-BE49-F0BBE249CD71Q35037959-A1EA50F2-823C-463F-B8BF-F4DC13C43884Q35090637-59000940-EFAD-4AC4-99D1-5470AEC17212Q35446894-D81E0111-F124-4D64-9D5E-46AE3D06D7B7Q35659141-E02C02E5-F0B6-4F90-AF52-5827EF0B3D06Q35953886-3A5E19B7-4EF2-42B6-B11D-9A6BB28CD65FQ36724965-A91A5798-BBC5-41AE-910B-60AD30CD8649Q36944895-58D80063-27E1-48C0-880D-EADD218B11A8Q37046351-B5F5C705-4A0A-4F74-8722-6E13E8DEE6E9Q37232088-D84CE617-FF49-4DEE-A0F8-054900969FA9Q37245282-9DDBC6B5-8ED7-4397-98F7-21F0F2A0C8F2Q37259576-9E0FB6EB-BFAA-43C6-9BD1-1D5136339D35Q37417513-088F60E6-2F7D-44AF-A0DC-08B66FD9CE16Q37445869-9C1310F2-63A1-40CC-B1D0-D3385F2D14F3Q37456054-4C63314E-1047-445B-9B8E-09586C030F9FQ37590630-B1BE9FA2-CCB1-4DFD-9A2F-AD144F741E99Q37737296-C051DAE0-153A-4EE6-86D8-BBEA5E57A810Q37896141-5700A8D0-BDE3-46A5-B16D-2635858CD484Q38087640-177DB716-C3C6-4B95-9C91-4BEC37724EEEQ38166965-F6703C26-55F2-441A-B57D-413D9100F5FDQ38186650-7D72FF5B-D10A-491D-8411-9EBA2C15EC8BQ38209851-C07E3E3E-0D70-490F-905E-87911F17780BQ38370609-4DA5083C-DC92-4874-A71E-A36B42AA2902Q38764851-D34DC1EE-EF37-4D12-BFBA-54042DCDEC11Q38809649-870EA8FA-4391-4DD9-8810-4BEA25BDE46A
P2860
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@ast
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@en
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@nl
type
label
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@ast
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@en
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@nl
prefLabel
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@ast
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@en
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@nl
P2093
P2860
P921
P356
P1476
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
@en
P2093
Gary W Small
Gregory M Cole
Jorge R Barrio
Kooresh Shoghi-Jadid
Linda Ercoli
Michael E Phelps
Nagichettiar Satyamurthy
Prabha Siddarth
Sung-Cheng Huang
Vladimir Kepe
P2860
P304
P356
10.1073/PNAS.0510237103
P407
P577
2006-01-09T00:00:00Z